The Engine (venture capital)

The Engine (venture capital)

A venture capital firm in Massachusetts that focuses on equipment, business guidance, and other resources, at MIT and beyond.

The Engine is a venture capital firm in Massachusetts that focuses on equipment, business guidance, and other resources, at MIT and beyond. Founded 2016 in Cambridge, Massachusetts, United States, it invests in series A, seed rounds, series B and venture rounds. Its portfolio companies include Lilac Solutions, ISEE, E25Bio, Form Energy, Cambridge Crops, Vaxess Technologies, Commonwealth Fusion, Kytopen, Zapata Computing, Cellino Biotech. As of March 2020, The Engine has made 23 investments. Their most recent investment was on February 20, 2020, when Lilac Solutions raised $20M. The company has raised a single venture fund, Tough Tech. This fund was announced on September 24, 2018 and raised a total of $204.5M.

Timeline

2016

Founded

Funded Companies

Company
Description
Website
Industry
Location

A technology company developing fusion power systems based on ARC tokamak reactors.

A satellite communications company making satellites equipped with RD-laser communications technology.

Using quantum physics to create a next generation, emission free photocatalytic chemical reactor for hydrogen production

Form Energy is a Somerville, Massachusetts-based company developing low-cost, long-duration energy storage systems.

Boston Metal is a Woburn, Massachusetts-based developer of molten oxide electrolysis technology for steel manufacturing.

7 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Ann DeWitt

COO & General Partner

Katie Rae

CEO and Managing Partner

Paula Anzer

Head of Network

Reed Sturtevant

General Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Cambridge Crops

E25Bio

Form Energy

ISEE

Lilac Solutions

Vaxess Technologies

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.